3.1 Our Team

Our Leadership Team

Eric Lefkosky Founder & CEO

Read Bio

Kevin White, PhD President

Read Bio

Erik Phelps Executive Vice President and General Counsel

Read Bio

Gary Palmer, MD Chief Medical Officer

Read Bio

Nike Beaubier, MD Director of Pathology and Medical Lab Operations

Read Bio

Ryan Fukushima Chief Operating Officer

Read Bio

Shane Colley Senior Vice President of Engineering

Read Bio

Kimberly Yeatts Senior Director of Clinical Lab Operations

Read Bio

Our Scientific Advisors

Dr. Andrea Califano Scientific Adviser

Read Bio

Arul Chinnaiyan, MD, PhD Scientific Adviser

Read Bio

David Agus, MD Scientific Adviser

Read Bio

Eric Topol, MD Scientific Adviser

Read Bio

Funmi Olopade, MD Scientific Adviser

Read Bio

Some Other Advisors

“Nowhere is technology more desperately needed than in healthcare. As a country, we spend over three trillion dollars annually. We have a social and economic imperative to improve our healthcare system: to make it better, more accessible, and more effective. I'm thrilled to have invested in Tempus and their team of innovators who are obsessed with developing breakthroughs in how we treat diseases.”

John Doerr, Chairman, Kleiner Perkins

“We are thrilled to have led an investment in Tempus... Given NEA's long and successful history investing in the intersection of technology and life science, we felt like the perfect strategic partner given Tempus' mission to help doctors personalize care by collecting and analyzing large volumes of data.”

Peter Barris, Chairman & General Partner, New Enterprise Associates

“Having spent my entire career at the forefront of emerging technologies, it’s exciting to see how healthcare is finally embracing the very technologies that have transformed so many other industries. This is a space that is near and dear to Jean and I, and we're excited to have invested in Tempus as they seek to bring big data, artificial intelligence and advanced molecular analysis to those suffering with cancer and other life threatening diseases”

Steve Case, Chairman and CEO, Revolution